Bicuspid Aortic ValveDevice
What this study is
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
What's being tested
- Transcatheter aortic valve replacement
Intervention · DEVICE
Study details
- Official title
- The International Multicenter Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
- Sponsor
- Cedars-Sinai Medical Center
- Conditions
- Bicuspid Aortic Valve
- Enrolling
- 2,000 people
- Starts
- 2016-08-15
- Est. completion
- 2028-08-15
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 19 Years – 129 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age≥18 years.
- Severe aortic stenosis with bicuspid anatomy.
- NYHA≥2 and/or syncope and/or angina.
- Patient judged by the Heart Team as indicated for TAVR.
You can't join if
- Age <18 years
- Asymptomatic patients
- Pure aortic regurgitation.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openCedars-Sinai Medical Center
Los Angeles, California, United States
- Sung-Han Yoon, M.D. · Contact310-423-7426Sunghan.Yoon@cshs.org
Recruiting
Study team
Sponsor
Cedars-Sinai Medical Center
Study ID Pro00047203
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.